November 30 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said that its consolidated net profit, excluding minority interest, fell to 6.3 million levs ($3.7 million/3.2 million euro) in the first nine months of the year from 7.2 million levs in the comparable period of 2017, despite a rise in revenue.